Incidence of tuberculosis among anti-TNF users in patients with previous history of tuberculosis

被引：0
|
作者：
Jo, Kyung-Wook [1 ]
Hong, YoonKi [2 ]
Jung, Young Ju [1 ]
Lee, Sang-Do [1 ]
Kim, Woo Sung [1 ]
Kim, Dong Soon [1 ]
Shim, Tae Sun [1 ]
机构：
[1] Asan Med Ctr, Dept Pulm & Crit Care Med, Seoul, South Korea
[2] Kangwon Natl Univ, Dept Internal Med, Chunchon, South Korea
来源：
EUROPEAN RESPIRATORY JOURNAL | 2013年 / 42卷
关键词：
Tuberculosis; -; management;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
2173
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Risk factors associated with pulmonary tuberculosis: smoking, diabetes and anti-TNFα drugs
    Ferrara, Giovanni
    Murray, Megan
    Winthrop, Kevin
    Centis, Rosella
    Sotgiu, Giovanni
    Migliori, Giovanni Battista
    Maeurer, Markus
    Zumla, Alimuddin
    CURRENT OPINION IN PULMONARY MEDICINE, 2012, 18 (03) : 233 - 240
  • [32] Stringent screening strategy significantly reduces reactivation rates of tuberculosis in patients with inflammatory bowel disease on anti-TNF therapy in tuberculosis endemic region
    Kumar, Peeyush
    Vuyyuru, Sudheer K.
    Kante, Bhaskar
    Sahu, Pabitra
    Goyal, Sandeep
    Madhu, Deepak
    Jain, Saransh
    Ranjan, Mukesh Kumar
    Mundhra, Sandeep
    Golla, Rithvik
    Singh, Mukesh
    Virmani, Shubi
    Gupta, Anvita
    Yadav, Nidhi
    Kalaivani, Mani
    Sharma, Raju
    Das, Prasenjit
    Makharia, Govind
    Kedia, Saurabh
    Ahuja, Vineet
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (11) : 1431 - 1440
  • [33] Assessing risk and managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNFα treatment
    Ormerod, LP
    CYTOKINE, 2004, 28 (4-5) : 179 - 181
  • [34] Experiences in anti-tuberculosis treatment in patients with multiple previous treatments and its impact on drug resistant tuberculosis epidemics
    Xu, Biao
    Zhao, Qi
    Hu, Yi
    Shi, Ying
    Wang, Weibing
    Diwan, Vinod K.
    GLOBAL HEALTH ACTION, 2014, 7
  • [35] Risk of developing tuberculosis under anti-TNF treatment despite latent infection screening
    Jauregui-Amezaga, Aranzazu
    Turon, Fanny
    Ordas, Ingrid
    Gallego, Marta
    Feu, Faust
    Ricart, Elena
    Panes, Julian
    JOURNAL OF CROHNS & COLITIS, 2013, 7 (03) : 208 - 212
  • [36] Emerging Tuberculosis Among Patients with Previous COVID-19
    Yakupogullari, Yusuf
    Tanriverdi, Elif Seren
    Ermis, Hilal
    Otlu, Baris
    FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI, 2022, 27 (04): : 659 - 663
  • [37] Safe Re-administration of Tumor Necrosis Factor-alpha (TNFα) Inhibitors in Patients with Rheumatoid Arthritis or Ankylosing Spondylitis Who Developed Active Tuberculosis on Previous Anti-TNFα Therapy
    Suh, Young Sun
    Kwok, Seung-ki
    Ju, Ji Hyeon
    Park, Kyung-Su
    Park, Sung-Hwan
    Yoon, Chong-Hyeon
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2014, 29 (01) : 38 - 42
  • [38] Incidence and nature of infectious disease in patients treated with anti-TNF agents
    Raychaudhuri, Siba P.
    Nguyen, Caroline T.
    Raychaudhuri, Smriti K.
    Gershwin, M. Eric
    AUTOIMMUNITY REVIEWS, 2009, 9 (02) : 67 - 81
  • [39] Tuberculosis infection following anti-TNF therapy in inflammatory bowel disease, despite negative screening
    Debeuckelaere, Celine
    De Munter, Paul
    Van Bleyenbergh, Pascal
    De Weyer, Walter
    Van Assche, Gert
    Rutgeerts, Paul
    Vermeire, Severine
    JOURNAL OF CROHNS & COLITIS, 2014, 8 (06) : 550 - 557
  • [40] Disseminated tuberculosis after anti-TNF alpha treatment: Do not blindly trust the IGRA test
    Delarbre, David
    Junca-Laplace, Camille
    Otto, Marie-Pierre
    Antoine, Carole
    Defuentes, Gilles
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2024, 42 (02): : 98 - 101
12345